Takeda Pharmaceutical Files 6-K Report
Ticker: TKPHF · Form: 6-K · Filed: Jul 9, 2025 · CIK: 1395064
| Field | Detail |
|---|---|
| Company | Takeda Pharmaceutical Co Ltd (TKPHF) |
| Form Type | 6-K |
| Filed Date | Jul 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: foreign-issuer, regulatory-filing
TL;DR
Takeda filed a 6-K on 7/9/25, standard foreign issuer report.
AI Summary
Takeda Pharmaceutical Company Limited filed a Form 6-K on July 9, 2025, reporting as a foreign private issuer. The filing indicates Takeda's principal executive offices are located in Tokyo, Japan, and it is subject to SEC Act of 1934.
Why It Matters
This filing provides routine updates for Takeda Pharmaceutical as a foreign private issuer, informing investors about its regulatory status and corporate information.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational news.
Key Players & Entities
- Takeda Pharmaceutical Company Limited (company) — Registrant
- 001-38757 (company) — SEC File Number
- 1934 Act (company) — SEC Act
- Tokyo (company) — City
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, used to furnish information which the registrant may be required to disclose or make public pursuant to the laws of its home country or the rules of any stock exchange on which it is listed.
What is Takeda Pharmaceutical's SEC file number?
Takeda Pharmaceutical's SEC file number is 001-38757.
Where are Takeda Pharmaceutical's principal executive offices located?
Takeda Pharmaceutical's principal executive offices are located at 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, 103-8668, Japan.
Is Takeda Pharmaceutical filing its annual report on Form 20-F or 40-F?
Takeda Pharmaceutical is filing its annual report on Form 20-F, as indicated by the checkmark next to it.
What is the filing date of this Form 6-K?
This Form 6-K was filed on July 9, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 9, 2025 regarding TAKEDA PHARMACEUTICAL CO LTD (TKPHF).